Regulation of low-density lipoprotein receptor expression during keratinocyte differentiation. 1991

M F te Pas, and P Lombardi, and L M Havekes, and J Boonstra, and M Ponec
Department of Dermatology, University Hospital Leiden, The Netherlands.

Transformed keratinocytes (i.e., SCC-4, SCC-15, SCC-12F2, SVK14) or normal keratinocytes which differ in their differentiation program, were used to study the regulation of low-density lipoprotein (LDL)-receptor expression. The capacity of the cells to differentiate was modulated by changing the extracellular calcium concentration. We now demonstrate that LDL-receptor expression in normal and transformed keratinocytes depends on the cell type and one or more levels of regulatory control. Cells express elevated mRNA levels when cultured under low Ca++ (proliferating) conditions. In contrast, SV40-transformed keratinocytes express decreased message under similar condition. In addition, LDL-receptor protein is decreased in transformed cells when extracellular Ca++ is increased (1.6 mM) to stimulate differentiation; the decrease in protein is comparable to the decrease in mRNA expression. Under the same conditions, normal keratinocytes show markedly decreased LDL-receptor protein relative to the decrease in mRNA. Incubation with LDL-cholesterol decreases the number of cell surface-exposed LDL-receptors. The LDL-receptor in fibroblasts is regulated differently from SCC-4 cells. The addition of LDL-cholesterol to fibroblasts causes decreased LDL-receptor mRNA and protein expression whereas SCC-4 cells show the opposite effect. The addition of cholesterol in non-lipoprotein form causes decreased LDL-receptor mRNA and protein expression in both cell types. These results suggest another, yet unidentified, regulatory mechanism that affects LDL-receptor expression in these two cell types.

UI MeSH Term Description Entries
D011973 Receptors, LDL Receptors on the plasma membrane of nonhepatic cells that specifically bind LDL. The receptors are localized in specialized regions called coated pits. Hypercholesteremia is caused by an allelic genetic defect of three types: 1, receptors do not bind to LDL; 2, there is reduced binding of LDL; and 3, there is normal binding but no internalization of LDL. In consequence, entry of cholesterol esters into the cell is impaired and the intracellular feedback by cholesterol on 3-hydroxy-3-methylglutaryl CoA reductase is lacking. LDL Receptors,Lipoprotein LDL Receptors,Receptors, Low Density Lipoprotein,LDL Receptor,LDL Receptors, Lipoprotein,Low Density Lipoprotein Receptor,Low Density Lipoprotein Receptors,Receptors, Lipoprotein, LDL,Receptor, LDL,Receptors, Lipoprotein LDL
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002461 Cell Line, Transformed Eukaryotic cell line obtained in a quiescent or stationary phase which undergoes conversion to a state of unregulated growth in culture, resembling an in vitro tumor. It occurs spontaneously or through interaction with viruses, oncogenes, radiation, or drugs/chemicals. Transformed Cell Line,Cell Lines, Transformed,Transformed Cell Lines
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D015536 Down-Regulation A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Down-Regulation,Down-Regulation (Physiology),Downregulation,Down Regulation,Down-Regulation, Receptor
D015603 Keratinocytes Epidermal cells which synthesize keratin and undergo characteristic changes as they move upward from the basal layers of the epidermis to the cornified (horny) layer of the skin. Successive stages of differentiation of the keratinocytes forming the epidermal layers are basal cell, spinous or prickle cell, and the granular cell. Keratinocyte

Related Publications

M F te Pas, and P Lombardi, and L M Havekes, and J Boonstra, and M Ponec
January 1990, Transactions of the Association of American Physicians,
M F te Pas, and P Lombardi, and L M Havekes, and J Boonstra, and M Ponec
January 1989, The Journal of biological chemistry,
M F te Pas, and P Lombardi, and L M Havekes, and J Boonstra, and M Ponec
March 1985, Biophysical chemistry,
M F te Pas, and P Lombardi, and L M Havekes, and J Boonstra, and M Ponec
October 1994, Journal of lipid research,
M F te Pas, and P Lombardi, and L M Havekes, and J Boonstra, and M Ponec
August 2006, Pharmacology & therapeutics,
M F te Pas, and P Lombardi, and L M Havekes, and J Boonstra, and M Ponec
November 2010, Journal of neurochemistry,
M F te Pas, and P Lombardi, and L M Havekes, and J Boonstra, and M Ponec
August 1989, Molecular endocrinology (Baltimore, Md.),
M F te Pas, and P Lombardi, and L M Havekes, and J Boonstra, and M Ponec
January 2010, Journal of cellular physiology,
M F te Pas, and P Lombardi, and L M Havekes, and J Boonstra, and M Ponec
January 2006, Journal of molecular medicine (Berlin, Germany),
M F te Pas, and P Lombardi, and L M Havekes, and J Boonstra, and M Ponec
August 1998, Journal of lipid research,
Copied contents to your clipboard!